Cardio Diagnostics Holdings, Inc. Proceeds from Notes Payable
Cardio Diagnostics Holdings, Inc. (CDIO) reported Proceeds from Notes Payable of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-11-07
- Cardio Diagnostics Holdings, Inc. proceeds from notes payable for the quarter ending 2022-09-30 was $0.00.
| Period end | Proceeds from Notes Payable 1 month | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 4 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 | ||||
| 2021-09-30 | $45.00K 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | $45.00K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |